StocksJohnson & JohnsonJNJ

JNJ

Johnson & Johnson

165.18 -1.69 (-1.01%)
Delayed Prices By NASDAQ, in USD Market Closed
Trade
S
165.18
B
165.53
Pinned Post
Dividend Income Stocks
Analyst Weekly – The recession playbook Learn about strategies on how to navigate recessions. 👓 🔹 Fears over a global recession have been at the forefront of investors' minds lately, with almost all central banks hiking interest rates in order to curb rising inflation. During these tough times,... Show More
Like CommentShare
Show more comments2 of 11
1 reply
null
.
Market Feed
Top
Stuart Allan English
$JNJ (Johnson & Johnson) - stock is hitting its lowest level since March. The shares have seen selling pressure over the two sessions; they were down about 3.2% at today’s low. While that's not exactly a harrowing decline, it is noteworthy that J&J hit its lowest stock price since early March. A... Show More
JNJ
Johnson & Johnson
165.18
-1.69 (-1.01%)
Trade
Andrea Aldea
⭐ ADA.DIVIDENDS PORTFOLIO – MARKET SUM ⭐ 𝐖𝐡𝐚𝐭 𝐡𝐚𝐩𝐩𝐞𝐧𝐞𝐝 𝐲𝐞𝐬𝐭𝐞𝐫𝐝𝐚𝐲 𝐀𝐮𝐠𝐮𝐬𝐭 𝟏𝟐? 🎯 U.S. equities ended the day and the week on a high note following reports suggesting that soaring inflation may finally be easing. The $DJ30, $SPX500, and $NSDQ100 made steady gains throughout... Show More Translate
Yohan Lenud
Salut à tous! 13/08/2022 Le point hebdomadaire: Performance de la semaine: +1.58% Les TOP: TOP3 UP: $META (Meta Platforms Inc) : +7.93% $EXR (Extra Space Storage Inc) : +7.41% $TTE.PA (TotalEnergies SE) : +6.40% TOP3 DOWN: $ML.PA (Compagnie Generale DES Etablissements Michelin SCA) : -2.19% $JNJ... Show More Translate
Patrick Ling
I am skeptical that peak inflation has occurred but at the same time, I respect recent market action. My style tends to be momentum driven so I also have some risk-on positions in my portfolio. They include: $UNH (UnitedHealth) $CVX (Chevron) $MRK (Merck & Co.) $KO (Coca-Cola) $AMGN (Amgen Inc) $TRV... Show More
Like CommentShare
2 replies
null
.
Avegail Cruz
J&J to end global sales of talc-based baby powder Johnson & Johnson will stop selling talc-based baby powder globally in 2023, the drugmaker said on Thursday, more than two years after it ended U.S. sales of a product that drew thousands of consumer safety lawsuits. In 2020, J&J announced that it would... Show More